Responses
Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
466 Combined inhibition of KRAS G12C and PD-1 boosts the therapeutic efficacy via conditioning of tumor microenvironment in pre-clinical humanized NSCLC mouse models
Compose a Response to This Article
Other responses
No responses have been published for this article.
